Acetazolamide Market
According to Intent Market Research, the Acetazolamide Market is expected to grow from USD 346.2 million in 2023 at a CAGR of 6.5% to touch USD 539.3 million by 2030. The Acetazolamide Market is dominated by key players such as, Alvogen, Inc., Alembic Pharmaceuticals Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals PLC.